Radiopharm Theranostics directors acquired Fully Paid Ordinary Shares and Listed Options under a Securities Purchase Plan, with share consideration shown as $25,000 at $0.009 per Share and options acquired for zero consideration. The notices give investors director-level ownership data, including direct and indirect holdings and option terms after the 17 September 2026 changes.
Key Highlights
- Bruce Goodwin acquired 2,777,778 Fully Paid Ordinary Shares and 2,777,778 Listed Options through the Securities Purchase Plan.
- Ian Turner’s post-acquisition holdings totalled 12,763,070 Shares and 24,805,126 Options across direct and indirect interests.
- Paul Hopper’s indirect holdings rose to 96,599,206 Shares and 11,795,296 Options after the transaction.
Radiopharm Theranostics Ltd (NASDAQ: RADX) recorded four changes in directors’ interests after securities were acquired through a Securities Purchase Plan. The changes took place on 17 September 2026, with share consideration listed at $25,000, or $0.009 per Share, while the Listed Options carried zero consideration.
Director Acquisitions Under Plan
Bruce Goodwin acquired 2,777,778 Fully Paid Ordinary Shares and 2,777,778 Listed Options through the plan. The options expire on 31 Jul 29 and carry an exercise price of $0.018. His post-change position showed 2,777,778 Shares and 2,777,778 Options, all classified as indirect interests. Ian Turner acquired securities in both direct and indirect categories. His direct Acquisition comprised 1,222,222 Fully Paid Ordinary Shares and 1,222,222 Listed Options, while the indirect acquisition comprised 1,555,556 Fully Paid Ordinary Shares and 1,555,556 Listed Options. Turner’s holdings after the change were listed at 3,752,817 direct Shares and 23,179,148 direct Options. His indirect position stood at 9,010,253 Shares and 1,625,978 Options, with total holdings of 12,763,070 Shares and 24,805,126 Options.
Paul Hopper’s Updated Interests
Hopper’s direct holdings remained listed at 53,900,000 Shares and 26,142,000 Options. His indirect holdings after the change were 96,599,206 Shares and 11,795,296 Options, taking his total position to 150,499,206 Shares and 37,937,296 Options. The consideration recorded for Hopper’s acquired Shares was $25,000 at $0.009 per Share, while the Listed Options were acquired for zero consideration.
Interest Notices Dated September 22
The notices identified the securities as Fully Paid Ordinary Shares and Listed Options. The notices stated that the interests were not traded during a closed period requiring prior written clearance. Radiopharm Theranostics also linked the acquisitions to participation in the Securities Purchase Plan after Shareholder approval at the 11 September 2026 extraordinary general meeting. The reported ownership positions therefore include direct and indirect interests where specified, as well as the associated Listed Options and their stated terms.



Please wait processing your request...